NovaBridge Biosciences (NBP) Income towards Parent Company (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Income towards Parent Company data on file, last reported at -$72.9 million in Q4 2025.

• Quarterly Income towards Parent Company changed N/A year-over-year to -$72.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$88.3 million (down 242.88% YoY) and the FY2024 annual result came in at $27.5 million, up 121.88% from the prior year.
• Income towards Parent Company declined to -$72.9 million in Q4 2025 per NBP's latest filing, from -$6.8 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $34.4 million in Q2 2024 and bottomed at -$72.9 million in Q4 2025.
• The 3-year median for Income towards Parent Company is -$5.5 million (2025), against an average of -$3.6 million.
• Peak annual rise in Income towards Parent Company reached 54.33% in 2025, while the deepest fall reached 119.87% in 2025.
• Tracing NBP's Income towards Parent Company over 3 years: stood at -$31.0 million in 2023, then surged by 210.89% to $34.4 million in 2024, then slumped by 312.02% to -$72.9 million in 2025.
• Per Business Quant, the three latest NBP Income towards Parent Company figures stand at -$72.9 million (Q4 2025), -$6.8 million (Q3 2025), and -$5.5 million (Q2 2025).

Peer Comparison